{"AllianceGenome": "8987", "HGNC": "8987", "MIM": "300295", "_id": "11040", "_version": 1, "accession": {"genomic": ["AB042425.1", "AC233300.2", "AF207550.3", "CH471224.1", "CP068255.2", "CQ834174.1", "CQ834176.1", "HI179046.1", "KT584470.1", "NC_000023.11", "NC_060947.1", "NG_016262.2", "NW_025791820.1"], "protein": ["AAC78506.1", "AAH18111.1", "BAA95613.1", "BAF83620.1", "CAH05302.1", "CAH05303.1", "CBX53832.1", "EAW50729.1", "EAW50730.1", "NP_006866.2", "Q9P1W9.1", "XP_047297748.1", "XP_054182379.1", "XP_054189374.1"], "rna": ["AK290931.1", "AK312745.1", "BC018111.1", "DC378253.1", "NM_006875.4", "U77735.1", "XM_047441792.1", "XM_054326404.1", "XM_054333399.1"], "translation": [{"protein": "XP_047297748.1", "rna": "XM_047441792.1"}, {"protein": "AAC78506.1", "rna": "U77735.1"}, {"protein": "NP_006866.2", "rna": "NM_006875.4"}, {"protein": "XP_054182379.1", "rna": "XM_054326404.1"}, {"protein": "AAH18111.1", "rna": "BC018111.1"}, {"protein": "XP_054189374.1", "rna": "XM_054333399.1"}, {"protein": "BAF83620.1", "rna": "AK290931.1"}]}, "ec": "2.7.11.1", "ensembl": [{"gene": "ENSG00000102096", "protein": ["ENSP00000365692", "ENSP00000518231"], "transcript": ["ENST00000376509", "ENST00000442430", "ENST00000485431", "ENST00000710360"], "translation": [{"protein": "ENSP00000365692", "rna": "ENST00000376509"}, {"protein": "ENSP00000518231", "rna": "ENST00000710360"}], "type_of_gene": "protein_coding"}, {"gene": "ENSG00000292210", "protein": ["ENSP00000518036", "ENSP00000518037"], "transcript": ["ENST00000710069", "ENST00000710070", "ENST00000710071"], "translation": [{"protein": "ENSP00000518036", "rna": "ENST00000710069"}, {"protein": "ENSP00000518037", "rna": "ENST00000710071"}], "type_of_gene": "protein_coding"}], "entrezgene": "11040", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 7.02104128395, "exp_mis": 72.3072656051, "exp_syn": 30.9749929464, "lof_z": 2.62476512779918, "mis_z": 1.51321718591083, "mu_lof": 8.52777279423e-07, "mu_mis": 1.12451945759e-05, "mu_syn": 4.64858725385e-06, "n_lof": 0.0, "n_mis": 46.0, "n_syn": 35.0, "p_li": 0.894760123149801, "p_null": 0.00102010186184734, "p_rec": 0.104219774988351, "syn_z": -0.448343472846209}, "bp": 936, "cds_end": 48776111, "cds_start": 48771407, "n_exons": 6, "nonpsych": {"exp_lof": 6.29627575065, "exp_mis": 65.5136148864, "exp_syn": 28.0235103109, "lof_z": 2.46430155009035, "mis_z": 1.71452354595631, "mu_lof": 8.52777279423e-07, "mu_mis": 1.12451945759e-05, "mu_syn": 4.64858725385e-06, "n_lof": 0.0, "n_mis": 38.0, "n_syn": 32.0, "p_li": 0.880827377869252, "p_null": 0.00170297461137015, "p_rec": 0.117469647519378, "syn_z": -0.472935732995999}, "nontcga": {"exp_lof": 6.37036568047, "exp_mis": 65.8322167396, "exp_syn": 28.1873133949, "lof_z": 2.48979414778883, "mis_z": 1.52477607130824, "mu_lof": 8.52777279423e-07, "mu_mis": 1.12451945759e-05, "mu_syn": 4.64858725385e-06, "n_lof": 0.0, "n_mis": 41.0, "n_syn": 29.0, "p_li": 0.873744038603625, "p_null": 0.00162842859895705, "p_rec": 0.124627532797418, "syn_z": -0.0969215605323177}, "transcript": "ENST00000376509.4"}, "exons": [{"cdsend": 48918834, "cdsstart": 48914130, "chr": "X", "position": [[48913181, 48914294], [48914394, 48914571], [48915019, 48915392], [48917780, 48917831], [48918535, 48918645], [48918773, 48919024]], "strand": -1, "transcript": "NM_006875", "txend": 48919024, "txstart": 48913181}], "exons_hg19": [{"cdsend": 48776111, "cdsstart": 48771407, "chr": "X", "position": [[48770458, 48771571], [48771671, 48771848], [48772296, 48772669], [48775057, 48775108], [48775812, 48775922], [48776050, 48776301]], "strand": -1, "transcript": "NM_006875", "txend": 48776301, "txstart": 48770458}], "generif": [{"pubmed": 12954615, "text": "pim-2 functions similarly to pim-1 as a pro-survival kinase; BAD is a legitimate PIM-2 substrate"}, {"pubmed": 15291354, "text": "hPim-2 mRNA expression in NHL was 1.5 to 2.6 times higher in involved splenic foci compared to nearby uninvolved regions. hPim-2 mRNA was increased 3-folds in B-CLL over normal B-cells"}, {"pubmed": 15548703, "text": "transcriptional induction of Pim-2 initiates a novel NF-kappaB activation pathway that regulates cell survival"}, {"pubmed": 15721354, "text": "EBV-induced upregulation of Pim kinases and Pim-stimulated EBNA2 transcriptional activity may contribute to the ability of EBV to immortalize B-cells and predispose them to malignant growth."}, {"pubmed": 16015593, "text": "Up-regulation of Pim-2 is associated with disease progression and perineural invasion in prostate cancer."}, {"pubmed": 16403219, "text": "All three Pim kinase family members predominantly phosphorylate Bad on Ser112 and in addition are capable of phosphorylating Bad on multiple sites associated with the inhibition of the pro-apoptotic function of Bad in HEK-293 cells"}, {"pubmed": 18216297, "text": "expression of the Myc and Pim proto-oncogenes by Jak2V617F was found to be FERM domain dependent."}, {"pubmed": 18424697, "text": "Foxp3 can regulate pim 2 expression."}, {"pubmed": 18593906, "text": "Pim kinases promote cell cycle progression and tumorigenesis by down-regulating p27(Kip1) expression at both transcriptional and posttranslational levels."}, {"pubmed": 18675992, "text": "pim-2 acts as a pro-survival kinase to inhibit apoptosis and keep liver cell survival in IL-3-deprived medium. Pim-2 might participate in the tumorigenesis of hepatocellular carcinoma induction through its downstream molecules 4E-BP1 and Bad."}, {"pubmed": 19821157, "text": "we infer that Pim-2 could activate API-5 to inhibit the apoptosis of liver cells, and NF-kappaB is the key regulator"}, {"pubmed": 19841674, "text": "structural analysis of the PIM2 kinase in complex with an organoruthenium inhibitor"}, {"pubmed": 20465571, "text": "PIM2 controls the expression of the pro-inflammatory cytokine IL-6."}, {"pubmed": 20592892, "text": "Data show that Pim-2 can induce malignant transformation of human liver cell line L02."}, {"pubmed": 20939820, "text": "A cell-based test system useful for rapid and inexpensive pre-screening of compounds capable of preventing Pim-mediated phosphorylation is discussed."}, {"pubmed": 21299464, "text": "Pax-5 may act as a transcription factor to modulate the expression of Pim-2 in B-cells"}, {"pubmed": 21475253, "text": "IL-6 and TNF family cytokines upregulate Pim-2 in bone marrow stromal cells and osteoclasts in multiple myeloma. This appears to be a novel anti-apoptotic mechanism for MM cell survival."}, {"pubmed": 21859846, "text": "Targeting cap-dependent translation blocks converging survival signals by AKT and PIM 1, 2 kinases in lymphoma"}, {"pubmed": 22506047, "text": "While PIM-2 can function as a potent survival factor, it can, under certain circumstances, exhibit pro-apoptotic effects as well."}, {"pubmed": 23209281, "text": "PIM kinases promote the production of IFNgamma, the hallmark cytokine produced by Th1 cells."}, {"pubmed": 23749639, "text": "our results identify eIF4B as a critical substrate of Pim kinases in mediating the activity of Abl oncogenes"}, {"pubmed": 23752607, "text": "Our data indicate that PIM-2 and NF-kappaB gene expression is increased in patients with acute myeloid leukemia and acute lymphoblastic leukemia. High PIM-2 expression is associated with complete remission rate in AML patients."}, {"pubmed": 23760264, "text": "Data indicate that PIM-2 is an upstream activator of E2F-1 and ATM in the ultraviolet damage response."}, {"pubmed": 23813671, "text": "Overexpression of pim-2 may inhibit the apoptosis of prostate cancer cells through phosphorylation of eIF4B, thus promoting tumorigenesis."}, {"pubmed": 23818547, "text": "Pim2 directly phosphorylates TSC2 on Ser-1798 and relieves the suppression of TSC2 on mTOR-C1, leading to multiple myeloma cells proliferation."}, {"pubmed": 24142698, "text": "PIM2 could directly phosphorylate PKM2 on the Thr-454 residue, resulting in an increase of PKM2 protein levels. Compared with wild type, PKM2 with the phosphorylation-defective mutation displayed a reduced effect on glycolysis."}, {"pubmed": 24505470, "text": "HIF-1A induced PIM2 expression in HepG2 cells via binding to the hypoxia-responsive elements (HREs) of the PIM2 promoter."}, {"pubmed": 24799066, "text": "Blocking the activities of PIM kinases(PIM1, PIM2 and PIM3) could prevent pancreatic cancer development. PIM kinases(PIM1, PIM2 and PIM3) may be a novel target for cancer therapy"}, {"pubmed": 25238262, "text": "Data demonstrate the role of PIM kinases in driving myeloid leukemia, and as candidate molecules for therapy against human malignancies."}, {"pubmed": 25854938, "text": "Persistent activation of STAT3 by PIM2-driven positive feedback loop for epithelial-mesenchymal transition in breast cancer."}, {"pubmed": 26064888, "text": "our findings will help to uncover novel signaling pathways between inflammations and oxidative stress in rheumatoid arthritis development and imply that Pim-2/mTORC1 pathway may be critical for the initiation of inflammatory reactions."}, {"pubmed": 26078709, "text": "Our findings suggest that Pim-2-mediated aerobic glycolysis is critical for monitoring Warburg effect in colorectal tumor cells, highlighting Pim-2 as a potential metabolic target for colorectal tumor therapy."}, {"pubmed": 26500282, "text": "We show that Pim2 inhibitors and proteasome inhibitors, such as bortezomib, have additive effects to inhibit the growth of myeloma cells, suggesting that Pim2 could be an interesting target for the treatment of multiple myeloma."}, {"pubmed": 26551340, "text": "A high percentage of urothelial carcinomas express Pim kinases. Pim expression differs in NILG, NIHG, and IHG lesions."}, {"pubmed": 26643319, "text": "PIM2 gene knockdown enhances the anti-proliferative effect of AZD1208 in non-Hodgkin lymphoma cell line."}, {"pubmed": 26764044, "text": "the elevated expression of PIM2 in blastic cells is associated with poor prognosis of AML patients and their resistance to induction therapy."}, {"pubmed": 27448973, "text": "show that PIM1 contributes to melanoma cell proliferation and tumor growth in vivo; however, the presence of PIM2 and PIM3 could also influence the outcome."}, {"pubmed": 27564460, "text": "Our data provide evidence for a novel role for Pim2 in the regulation of the DNA damage response (DDR). Knockdown of Pim2 upregulates several downstream DDR markers, mimicking the effects of doxorubicin (Dox) treatment of MM cells, and suggesting a role for the kinase as a negative regulator of this pathway."}, {"pubmed": 27901106, "text": "data suggest that PIM1/2 kinase overexpression is a common feature of male reproductive organs tumors, which provoke tissue alterations and a large inflammatory response that may act synergistically during the process of tumorigenesis."}, {"pubmed": 28698206, "text": "PIM kinases in classical Hodgkin lymphoma exhibit pleiotropic effects, orchestrating tumor immune escape and supporting Reed-Sternberg cell survival."}, {"pubmed": 28729093, "text": "These results demonstrate the involvement of PIM kinases in LIF-induced regulation in different trophoblastic cell lines which may indicate similar functions in primary cells."}, {"pubmed": 28914261, "text": "we showed that RPS6KA3 knockdown reduced the propagation of human AML cells in vivo in mice. Our results point to RSK2 as a novel Pim2 target with translational therapeutic potential in FLT3-ITD AML."}, {"pubmed": 28944837, "text": "Inhibition of PIM2 attenuated asthma symptoms and increased expression levels of interleukin (IL)10 and forkhead box protein 3 (FOXP3) in bronchoalveolar lavage fluid."}, {"pubmed": 29124675, "text": "High PIM2 expression is associated with Malignant Grade in Prostate Cancer."}, {"pubmed": 29570932, "text": "These findings demonstrate an important role for the PIM2-TTP complex in breast cancer tumorigenesis."}, {"pubmed": 29665227, "text": "PIM2 is associated with unfavourable chronic lymphocytic leukaemia prognosis.PIM-2 role in the CXCR4-induced chronic lymphocytic leukaemia cell migration."}, {"pubmed": 29985480, "text": "our findings indicated that PIM2 was a novel regulator of HK2, and suggested a new strategy to treat breast cancer."}, {"pubmed": 30096294, "text": "PIM2 is upregulated by strongly activated tumor suppressor protein p53."}, {"pubmed": 30340823, "text": "PIM2 might function as an important oncogene in gastric cancer"}, {"pubmed": 31358902, "text": "Phosphorylation of AMPKalpha1 by PIM2 led to decreasing AMPKalpha1 kinase activity, which in turn promoted aerobic glycolysis and tumor growth. In addition, PIM2 expression positively correlated with AMPKalpha1 Thr467 phosphorylation in Endometrial cancer tissues. Insights into the role of PIM2 and AMPKalpha1 in Endometrial cancer suggest that combination targeting of these proteins may represent a new strategy for tre..."}, {"pubmed": 31409638, "text": "HSF1 protein stability is regulated by PIM2-mediated phosphorylation of HSF1 at Thr120. PIM2, pThr120-HSF1, and PD-L1 expression positively correlated with each other in breast cancer tissues."}, {"pubmed": 31501481, "text": "TRAF3 regulates the oncogenic proteins Pim2 and c-Myc to restrain survival in normal and malignant B cells."}, {"pubmed": 31894300, "text": "Inhibition of PIM2 in liver cancer decreases tumor cell proliferation in vitro and in vivo primarily through the modulation of cell cycle progression."}, {"pubmed": 32641749, "text": "PIM2 promotes hepatocellular carcinoma tumorigenesis and progression through activating NF-kappaB signaling pathway."}, {"pubmed": 32754266, "text": "Fructose-1, 6-bisphosphatase 1 interacts with NF-kappaB p65 to regulate breast tumorigenesis via PIM2 induced phosphorylation."}, {"pubmed": 33931981, "text": "Positive regulation of PFKFB3 by PIM2 promotes glycolysis and paclitaxel resistance in breast cancer."}, {"pubmed": 34511042, "text": "Long non-coding RNA SOX21-AS1 modulates lung cancer progress upon microRNA miR-24-3p/PIM2 axis."}, {"pubmed": 35108359, "text": "PIM2 kinase has a pivotal role in plasmablast generation and plasma cell survival, opening up novel treatment options in myeloma."}, {"pubmed": 36109523, "text": "Phosphorylation of PFKFB4 by PIM2 promotes anaerobic glycolysis and cell proliferation in endometriosis."}, {"pubmed": 37059967, "text": "PIM2 Promotes the Development of Ovarian Endometriosis by Enhancing Glycolysis and Fibrosis."}], "genomic_pos": [{"chr": "X", "end": 48919024, "ensemblgene": "ENSG00000102096", "start": 48913182, "strand": -1}, {"chr": "HSCHRX_3_CTG3", "end": 77859, "ensemblgene": "ENSG00000292210", "start": 72017, "strand": -1}], "genomic_pos_hg19": [{"chr": "HG1436_HG1432_PATCH", "end": 48778423, "start": 48772581, "strand": -1}, {"chr": "X", "end": 48776301, "start": 48770459, "strand": -1}], "go": {"BP": [{"evidence": "IDA", "gocategory": "BP", "id": "GO:0000082", "pubmed": 20307683, "qualifier": "involved_in", "term": "G1/S transition of mitotic cell cycle"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0006468", "pubmed": 18593906, "qualifier": "involved_in", "term": "protein phosphorylation"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0006468", "qualifier": "involved_in", "term": "protein phosphorylation"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0007346", "qualifier": "involved_in", "term": "regulation of mitotic cell cycle"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0008285", "pubmed": 20307683, "qualifier": "involved_in", "term": "negative regulation of cell population proliferation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0008637", "qualifier": "involved_in", "term": "apoptotic mitochondrial changes"}, {"evidence": "IEP", "gocategory": "BP", "id": "GO:0009615", "pubmed": 16548883, "qualifier": "involved_in", "term": "response to virus"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0010508", "qualifier": "involved_in", "term": "positive regulation of autophagy"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0016236", "qualifier": "involved_in", "term": "macroautophagy"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0016239", "qualifier": "involved_in", "term": "positive regulation of macroautophagy"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0043066", "qualifier": "involved_in", "term": "negative regulation of apoptotic process"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0043066", "pubmed": 18675992, "qualifier": "involved_in", "term": "negative regulation of apoptotic process"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0043123", "qualifier": "involved_in", "term": "positive regulation of canonical NF-kappaB signal transduction"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0045893", "qualifier": "involved_in", "term": "positive regulation of DNA-templated transcription"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0046777", "qualifier": "involved_in", "term": "protein autophosphorylation"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0050821", "pubmed": 20307683, "qualifier": "involved_in", "term": "protein stabilization"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0050821", "qualifier": "involved_in", "term": "protein stabilization"}], "CC": {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005737", "qualifier": "is_active_in", "term": "cytoplasm"}, "MF": [{"category": "MF", "evidence": "IBA", "id": "GO:0004674", "qualifier": "enables", "term": "protein serine/threonine kinase activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0004674", "pubmed": 18593906, "qualifier": "enables", "term": "protein serine/threonine kinase activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [16713569, 25416956, 32814053], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0005524", "qualifier": "enables", "term": "ATP binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0106310", "qualifier": "enables", "term": "protein serine kinase activity"}]}, "homologene": {"genes": [[7955, 58054], [9544, 711844], [9598, 473600], [9606, 11040], [9615, 442959], [9913, 508424], [10090, 18715], [10116, 317366]], "id": 17098}, "interpro": [{"desc": "Protein kinase domain", "id": "IPR000719", "short_desc": "Prot_kinase_dom"}, {"desc": "Serine/threonine-protein kinase, active site", "id": "IPR008271", "short_desc": "Ser/Thr_kinase_AS"}, {"desc": "Protein kinase-like domain superfamily", "id": "IPR011009", "short_desc": "Kinase-like_dom_sf"}, {"desc": "Protein kinase, ATP binding site", "id": "IPR017441", "short_desc": "Protein_kinase_ATP_BS"}, {"desc": "Serine/threonine-protein kinase pim-1/2/3", "id": "IPR017348", "short_desc": "PIM1/2/3"}], "ipi": ["IPI00332692", "IPI00647683"], "map_location": "Xp11.23", "name": "Pim-2 proto-oncogene, serine/threonine kinase", "other_names": ["pim-2 oncogene", "pim-2h", "proto-oncogene Pim-2 (serine threonine kinase)", "serine/threonine-protein kinase pim-2"], "pantherdb": {"HGNC": "8987", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "97587", "ortholog_type": "LDO", "panther_family": "PTHR22984", "taxid": 10090, "uniprot_kb": "Q62070"}, {"RGD": "1560759", "ortholog_type": "LDO", "panther_family": "PTHR22984", "taxid": 10116, "uniprot_kb": "F1M419"}, {"ZFIN": "ZDB-GENE-000831-6", "ortholog_type": "O", "panther_family": "PTHR22984", "taxid": 7955, "uniprot_kb": "Q9YHZ5"}, {"ZFIN": "ZDB-GENE-050809-111", "ortholog_type": "O", "panther_family": "PTHR22984", "taxid": 7955, "uniprot_kb": "E7FB10"}, {"WormBase": "WBGene00004182", "ortholog_type": "O", "panther_family": "PTHR22984", "taxid": 6239, "uniprot_kb": "K8ESD7"}], "uniprot_kb": "Q9P1W9"}, "pathway": {"kegg": [{"id": "hsa05200", "name": "Pathways in cancer - Homo sapiens (human)"}, {"id": "hsa05221", "name": "Acute myeloid leukemia - Homo sapiens (human)"}], "wikipathways": [{"id": "WP3640", "name": "Imatinib and Chronic Myeloid Leukemia"}, {"id": "WP4566", "name": "Translation inhibitors in chronically activated PDGFRA cells"}]}, "pdb": ["2IWI", "4X7Q"], "pfam": "PF00069", "pharmgkb": "PA33319", "pharos": {"target_id": 16339, "tdl": "Tchem"}, "prosite": "PS50011", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF262207", "relationship": "is"}, {"id": "GNF262208", "relationship": "is"}, {"id": "GNF262209", "relationship": "is"}, {"id": "GNF262210", "relationship": "is"}], "GNF_hs-ORFeome1_1_reads": {"id": "GNF161637", "relationship": "is"}, "GNF_hs-Origene": [{"id": "GNF040815", "relationship": "is"}, {"id": "GNF048013", "relationship": "similar to"}], "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF087559", "relationship": "is"}, {"id": "GNF087560", "relationship": "is"}, {"id": "GNF087561", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF054068", "relationship": "is"}, {"id": "GNF058848", "relationship": "is"}, {"id": "GNF074132", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF065443", "relationship": "is"}, {"id": "GNF065444", "relationship": "is"}], "GNF_hs-pkinase_IDT-siRNA": [{"id": "GNF166480", "relationship": "is"}, {"id": "GNF166481", "relationship": "is"}, {"id": "GNF166482", "relationship": "is"}, {"id": "GNF166483", "relationship": "is"}], "GNF_hs_LentiORF-HA-MYC": {"id": "GNF282944", "relationship": "is"}, "GNF_hs_LentiORF-Jred": {"id": "GNF283871", "relationship": "is"}, "GNF_mm+hs-MGC": {"id": "GNF011243", "relationship": "is"}, "GNF_mm+hs_RetroCDNA": {"id": "GNF235237", "relationship": "is"}, "Invitrogen_IVTHSSIPKv2": [{"id": "GNF324180", "relationship": "is"}, {"id": "GNF324181", "relationship": "is"}], "NIBRI_hs-Secretome_pDEST": {"id": "GNF337377", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF092767", "relationship": "is"}, {"id": "GNF132465", "relationship": "is"}, {"id": "GNF148122", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000023.11", "NC_060947.1", "NG_016262.2", "NW_025791820.1"], "protein": ["NP_006866.2", "XP_047297748.1", "XP_054182379.1", "XP_054189374.1"], "rna": ["NM_006875.4", "XM_047441792.1", "XM_054326404.1", "XM_054333399.1"], "translation": [{"protein": "NP_006866.2", "rna": "NM_006875.4"}, {"protein": "XP_054182379.1", "rna": "XM_054326404.1"}, {"protein": "XP_047297748.1", "rna": "XM_047441792.1"}, {"protein": "XP_054189374.1", "rna": "XM_054333399.1"}]}, "reporter": {"HG-U133_Plus_2": "204269_at", "HG-U95Av2": ["1633_g_at", "1652_at"], "HTA-2_0": "TC0X001020.hg.1", "HuEx-1_0": "4007617", "HuGene-1_1": "8172471", "HuGene-2_1": "17110670"}, "summary": "This gene encodes a protooncogene that acts as a serine/threonine protein kinase. Studies determined the encoded protein functions to prevent apoptosis and to promote cell survival.[provided by RefSeq, Nov 2009].", "symbol": "PIM2", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1418581"}, "unigene": "Hs.727148", "uniprot": {"Swiss-Prot": "Q9P1W9", "TrEMBL": ["A0AA34QVH7", "A0AAG2UW48"]}, "wikipedia": {"url_stub": "PIM2 (gene)"}}